21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Stock analysis for AbbVie Inc (ABBV:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Learn about ABBV (XNYS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Monthly Subscription. View all upcoming and past events. Access detailed information about the AbbVie Inc (ABBV) Share including Price, Charts, Technical Analysis, Historical data, AbbVie Reports and more. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie … Shares are also listed … AbbVie stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for ABBV in the last 3 months. The Internet site that you have requested may not be optimized to your screen size. AbbVie And Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets By PR Newswire Dec 2, 2020 8:00 AM EST So far in 2019, AbbVie's share price has fallen by a double-digit percentage. $33.03. But AbbVie stock has faced its fair share of challenges in 2020. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. Follow ABBV. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. AbbVie Inc. share price in real-time (A1J84E / US00287Y1091), charts and analyses, news, key data, turnovers, company data. Banks and financial organisations issue their analysis forecasting how a particular stock will performance in the future. AbbVie has seen better days. About the AbbVie, Inc. stock forecast. The shares are currently trading at $107.15. The Abbvie Inc PE ratio based on its reported earnings over the past 12 months is 22.8. Free trial. To help understand and contextualize the model's evaluation of ABBV, investors may wish to consider are: As for its position relative to other Healthcare stocks that issue dividends, AbbVie Inc offers a higher dividend yield than 98.33% of them. Compare. Explore (Common Stock) Common Stock. AbbVie Inc. company facts, information and financial ratios from MarketWatch. Get AbbVie stock price history and adjusted historical data with charts, graphs, and statistical analysis. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. If you are a small trader you shouldn't invest based on these forecasts. Dive deeper with interactive charts and top stories of ABBVIE INC.. Events & presentations Upcoming events and latest webcast. AbbVie Stock Price . Learn More. News & Research. Company Profile. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie. Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations. 107.15 1.88 (1.79%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! Yes. The AbbVie Thesis. Price. for only. ABBVIE INC. (NYSE:ABBV) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ABBVIE INC. | Nyse: ABBV | Nyse As for ABBV, the DDM model, as implemented by StockNews, implies a positive return of 156.08% relative to its current price. View AbbVie Inc. ABBV investment & stock information. The principal market of AbbVie's common shares is the New York Stock Exchange. New. The average AbbVie stock price prediction forecasts a potential upside of 6.74% from the current ABBV share price of $107.15. Randall Stanicky upgraded AbbVie from Sector Perform to Outperform and increased the price target from $79 to $93. $80.29. AbbVie Inc live price charts and stock performance over time. AbbVie stock price forecast. VAT not included. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. Free trial. The all-time high AbbVie stock closing price was 123.21 on January 26, 2018.; The AbbVie 52-week high stock price is 109.15, which is 1.9% above the current share price. ABBV - AbbVie Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. The 12-month stock price forecast is 115.71, which is an increase of 7.99% from the latest price. Historical daily share price chart and data for AbbVie since 2021 adjusted for splits. View the latest ABBV stock quote and chart on MSN Money. Ihre Produkte sind für die Behandlung von rheumatoider Arthritis, Psoriasis, Morbus Crohn, Schilddrüsenerkrankungen, Parkinson, HIV, Komplikationen der Mukoviszidose, niedrigem Testosteronspiegel und Komplikationen im Zusammenhang mit chronischen Nierenerkrankungen … AbbVie is selling for under 106.34 as of the 15th of December 2020; that is 2.05% increase since the beginning of the trading day. The stock's lowest day price was 105.58. What is ABBV's earnings growth forecast for 2021-2023? for only. As of 2021 January 04, Monday current price of ABBV stock is 107.150$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. AbbVie, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. AbbVie paid Allergan a price of $120.30 in cash and 0.8660 AbbVie shares per Allergan share… The latest closing stock price for AbbVie as of December 31, 2020 is 107.15.. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. It is calculated by dividing a company's price per share by its earnings per share. AbbVie Inc. Common Stock (ABBV) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Small Cap Basic. After a 54% gain in 2017, the big-pharma stock lost ground last year. Monthly Subscription. AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. Nobody knows how much a share will be priced tomorrow. AbbVie Inc. ist auf die Erforschung und Entwicklung therapeutischer Arzneimittel spezialisiert. Get the latest AbbVie Inc (ABBV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Change. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. for only. Ultimate Trader (Monthly) Monthly Subscription. ... Transaction Type Share Price Shares Value; Dec 10, 2020 Sale: Jeffrey Ryan Stewart SVP, US … It announced a definitive agreement to buy Allergan on Jun 24, 2019. The following table shows the price forecasts published by financial institutions in the last month. AbbVie Aktie: WKN A1J84E - ISIN US00287Y1091 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu AbbVie. Big Cap Pro. Trading Ideas. Accept. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Often stocks with rapidly growing dividends have lower yields because investors who value that growth are willing to trade off current yield to get it and bid up the stock price. According to 22 analysts, the average rating for AbbVie stock is "Buy." Disclaimer Notice - Important. Payout Estimate. AbbVie is United States Stock traded on New York Stock Exchange Explore . The 12-month stock price forecast is 115.71, which is an increase of 7.99% from the latest price. Default Reject Description . Payout History. Do you wish to leave this site? AbbVie came into existence on Jan 1, 2013, after Abbott Laboratories divested its pharmaceutical division. Free trial. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. $52.04 .